| Authors: |
Ratnakumaran R; The Royal Marsden NHS Foundation Trust, London, United Kingdom; Radiotherapy and Imaging Division, Institute of Cancer Research, London, United Kingdom. Electronic address: ragu.ratnakumaran@icr.ac.uk., Sasitharan A; Radiotherapy and Imaging Division, Institute of Cancer Research, London, United Kingdom., Khan A; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Mayet H; Radiotherapy and Imaging Division, Institute of Cancer Research, London, United Kingdom., Mohajer J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Hinder V; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Brand DH; Department of Medical Physics and Bioengineering, University College London, London, United Kingdom., Fullarton R; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Loblaw A; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., van As N; The Royal Marsden NHS Foundation Trust, London, United Kingdom; Radiotherapy and Imaging Division, Institute of Cancer Research, London, United Kingdom., Tree AC; The Royal Marsden NHS Foundation Trust, London, United Kingdom; Radiotherapy and Imaging Division, Institute of Cancer Research, London, United Kingdom. |